Cargando…

229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)

Detalles Bibliográficos
Autores principales: Djurmez, O.I., Calamac, M.D., Dimitrijevic, M., Vukosavljevic, J.G., Serovic, K., Oblakovic-Babic, J., Stanic, N.S., Minic, I.Z., Tomasevic, Z., Bozovic Spasojevic, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069435/
http://dx.doi.org/10.1016/j.annonc.2022.03.250
_version_ 1784700429750239232
author Djurmez, O.I.
Calamac, M.D.
Dimitrijevic, M.
Vukosavljevic, J.G.
Serovic, K.
Oblakovic-Babic, J.
Stanic, N.S.
Minic, I.Z.
Tomasevic, Z.
Bozovic Spasojevic, I.
author_facet Djurmez, O.I.
Calamac, M.D.
Dimitrijevic, M.
Vukosavljevic, J.G.
Serovic, K.
Oblakovic-Babic, J.
Stanic, N.S.
Minic, I.Z.
Tomasevic, Z.
Bozovic Spasojevic, I.
author_sort Djurmez, O.I.
collection PubMed
description
format Online
Article
Text
id pubmed-9069435
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90694352022-05-04 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS) Djurmez, O.I. Calamac, M.D. Dimitrijevic, M. Vukosavljevic, J.G. Serovic, K. Oblakovic-Babic, J. Stanic, N.S. Minic, I.Z. Tomasevic, Z. Bozovic Spasojevic, I. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-05 2022-05-05 /pmc/articles/PMC9069435/ http://dx.doi.org/10.1016/j.annonc.2022.03.250 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Djurmez, O.I.
Calamac, M.D.
Dimitrijevic, M.
Vukosavljevic, J.G.
Serovic, K.
Oblakovic-Babic, J.
Stanic, N.S.
Minic, I.Z.
Tomasevic, Z.
Bozovic Spasojevic, I.
229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)
title 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)
title_full 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)
title_fullStr 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)
title_full_unstemmed 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)
title_short 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)
title_sort 229p efficiency of sars-cov-2 vaccines in breast cancer patients: single institutional experience from institute for oncology and radiology of serbia (iors)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069435/
http://dx.doi.org/10.1016/j.annonc.2022.03.250
work_keys_str_mv AT djurmezoi 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT calamacmd 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT dimitrijevicm 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT vukosavljevicjg 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT serovick 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT oblakovicbabicj 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT stanicns 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT miniciz 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT tomasevicz 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors
AT bozovicspasojevici 229pefficiencyofsarscov2vaccinesinbreastcancerpatientssingleinstitutionalexperiencefrominstituteforoncologyandradiologyofserbiaiors